KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Net Income towards Common Stockholders (2018 - 2025)

Historic Net Income towards Common Stockholders for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to -$5.9 million.

  • ClearPoint Neuro's Net Income towards Common Stockholders fell 1843.59% to -$5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.4 million, marking a year-over-year decrease of 2834.27%. This contributed to the annual value of -$19.7 million for FY2024, which is 1202.89% up from last year.
  • Per ClearPoint Neuro's latest filing, its Net Income towards Common Stockholders stood at -$5.9 million for Q3 2025, which was down 1843.59% from -$5.8 million recorded in Q2 2025.
  • ClearPoint Neuro's 5-year Net Income towards Common Stockholders high stood at -$2.5 million for Q1 2021, and its period low was -$7.1 million during Q2 2023.
  • In the last 5 years, ClearPoint Neuro's Net Income towards Common Stockholders had a median value of -$4.5 million in 2022 and averaged -$4.7 million.
  • As far as peak fluctuations go, ClearPoint Neuro's Net Income towards Common Stockholders plummeted by 15829.39% in 2021, and later skyrocketed by 3818.54% in 2024.
  • Quarter analysis of 5 years shows ClearPoint Neuro's Net Income towards Common Stockholders stood at -$4.0 million in 2021, then decreased by 12.23% to -$4.5 million in 2022, then fell by 5.3% to -$4.7 million in 2023, then fell by 20.02% to -$5.6 million in 2024, then dropped by 4.3% to -$5.9 million in 2025.
  • Its Net Income towards Common Stockholders was -$5.9 million in Q3 2025, compared to -$5.8 million in Q2 2025 and -$6.0 million in Q1 2025.